
|Articles|December 1, 2007
Can studies funded by manufacturers yield valid, objective results?
With the decreases in government funding of medical trials, manufacturers of the products being tested finance more and more clinical trials, whether for medication, therapies or equipment. Tests are obviously needed to determine the effectiveness and safety of new products in order to make medical progress. That system, however, can put unpredictable pressure on physicians conducting the trials.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming
2
Social Media Mythbusters: Skin Cycling
3
Quality of Life in CSU Shaped by More Than Skin Symptoms
4
KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show
5














